Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced Parathyroid Carcinoma
NCT07843901Phase 2Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Nov 2026
- Primary completion
- Aug 2028
01
Overview
A Phase 2 trial of lenvatinib in parathyroid carcinoma, sponsored by Yonsei University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
lenvatinib
03
Conditions
parathyroid carcinoma
Beyond the preview
Go deeper on NCT07843901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843901.